Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.43617441 |
2 | negative regulation of cell killing (GO:0031342) | 5.82275911 |
3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.82275911 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.78370227 |
5 | leukocyte aggregation (GO:0070486) | 5.33337414 |
6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.20925975 |
7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.20779098 |
8 | neutrophil activation involved in immune response (GO:0002283) | 5.07996281 |
9 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.01256378 |
10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.80592076 |
11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.80554440 |
12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.79400210 |
13 | detection of other organism (GO:0098543) | 4.74125741 |
14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.67068291 |
15 | detection of bacterium (GO:0016045) | 4.66007629 |
16 | modulation by symbiont of host defense response (GO:0052031) | 4.53498791 |
17 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.53498791 |
18 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.53498791 |
19 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.53498791 |
20 | modulation by symbiont of host immune response (GO:0052553) | 4.53498791 |
21 | positive regulation by symbiont of host defense response (GO:0052509) | 4.53498791 |
22 | negative T cell selection (GO:0043383) | 4.51606297 |
23 | negative thymic T cell selection (GO:0045060) | 4.36613454 |
24 | positive regulation of B cell differentiation (GO:0045579) | 4.36475482 |
25 | positive thymic T cell selection (GO:0045059) | 4.35262682 |
26 | cellular extravasation (GO:0045123) | 4.27571407 |
27 | neutrophil activation (GO:0042119) | 4.16320300 |
28 | response to peptidoglycan (GO:0032494) | 4.10453049 |
29 | immunoglobulin mediated immune response (GO:0016064) | 4.07340131 |
30 | response to interleukin-15 (GO:0070672) | 4.03097796 |
31 | positive T cell selection (GO:0043368) | 3.99968977 |
32 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.95947220 |
33 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.95086844 |
34 | regulation of B cell differentiation (GO:0045577) | 3.93439567 |
35 | respiratory burst (GO:0045730) | 3.82877452 |
36 | detection of external biotic stimulus (GO:0098581) | 3.80084306 |
37 | B cell receptor signaling pathway (GO:0050853) | 3.78479038 |
38 | cellular response to interleukin-15 (GO:0071350) | 3.72222463 |
39 | regulation of mast cell degranulation (GO:0043304) | 3.72145060 |
40 | granulocyte activation (GO:0036230) | 3.69647909 |
41 | mast cell activation (GO:0045576) | 3.69507920 |
42 | macrophage activation involved in immune response (GO:0002281) | 3.64148074 |
43 | leukocyte degranulation (GO:0043299) | 3.64022697 |
44 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.63664491 |
45 | negative regulation of interleukin-12 production (GO:0032695) | 3.63573958 |
46 | myeloid cell activation involved in immune response (GO:0002275) | 3.63487676 |
47 | positive regulation of granulocyte differentiation (GO:0030854) | 3.62590331 |
48 | T cell selection (GO:0045058) | 3.61305973 |
49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.61178149 |
50 | response to host immune response (GO:0052572) | 3.60213811 |
51 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.60213811 |
52 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56089807 |
53 | thymic T cell selection (GO:0045061) | 3.52145735 |
54 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.48039165 |
55 | T cell migration (GO:0072678) | 3.44670669 |
56 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.43826290 |
57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.40050415 |
58 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.36796160 |
59 | detection of biotic stimulus (GO:0009595) | 3.36641294 |
60 | response to muramyl dipeptide (GO:0032495) | 3.35774634 |
61 | microglial cell activation (GO:0001774) | 3.35584575 |
62 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.34701205 |
63 | regulation of regulatory T cell differentiation (GO:0045589) | 3.32385527 |
64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.30932538 |
65 | B cell mediated immunity (GO:0019724) | 3.30880060 |
66 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.29567668 |
67 | activated T cell proliferation (GO:0050798) | 3.29202801 |
68 | regulation of T cell tolerance induction (GO:0002664) | 3.26093274 |
69 | regulation of tolerance induction (GO:0002643) | 3.24628601 |
70 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.24041021 |
71 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.23706961 |
72 | response to host (GO:0075136) | 3.23706961 |
73 | response to host defenses (GO:0052200) | 3.23706961 |
74 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23001720 |
75 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22864435 |
76 | negative regulation of phagocytosis (GO:0050765) | 3.21953976 |
77 | cellular response to type I interferon (GO:0071357) | 3.19010468 |
78 | type I interferon signaling pathway (GO:0060337) | 3.19010468 |
79 | regulation of mast cell activation (GO:0033003) | 3.17798533 |
80 | neutrophil mediated immunity (GO:0002446) | 3.16443344 |
81 | response to type I interferon (GO:0034340) | 3.16373502 |
82 | negative regulation of innate immune response (GO:0045824) | 3.10713371 |
83 | detection of molecule of bacterial origin (GO:0032490) | 3.10444079 |
84 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.10182385 |
85 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.08893523 |
86 | positive regulation of tolerance induction (GO:0002645) | 3.08680421 |
87 | regulation of leukocyte degranulation (GO:0043300) | 3.08229425 |
88 | tolerance induction (GO:0002507) | 3.06126943 |
89 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.03462989 |
90 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.03462989 |
91 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.02574836 |
92 | negative regulation of interleukin-6 production (GO:0032715) | 3.01779179 |
93 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.99357928 |
94 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.99357928 |
95 | defense response to protozoan (GO:0042832) | 2.98349471 |
96 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91754574 |
97 | positive regulation of mast cell activation (GO:0033005) | 2.91652148 |
98 | NIK/NF-kappaB signaling (GO:0038061) | 2.91131583 |
99 | macrophage activation (GO:0042116) | 2.90141693 |
100 | mast cell activation involved in immune response (GO:0002279) | 2.89409108 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.89204387 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.68199900 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.48903448 |
4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.72210488 |
5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.72124214 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.51756747 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.21105094 |
8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.07747480 |
9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.01860074 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.99753786 |
11 | MYB_26560356_Chip-Seq_TH2_Human | 2.93485311 |
12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.86918954 |
13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.83561533 |
14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.82976908 |
15 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.78166553 |
16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.77297984 |
17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.68285486 |
18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.66030249 |
19 | MAF_26560356_Chip-Seq_TH1_Human | 2.60920588 |
20 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.57592541 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49869422 |
22 | MYC_22102868_ChIP-Seq_BL_Human | 2.45056665 |
23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.44363883 |
24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40639608 |
25 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.39942969 |
26 | MYB_26560356_Chip-Seq_TH1_Human | 2.39414934 |
27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.35700159 |
28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.35628251 |
29 | SPI1_23127762_ChIP-Seq_K562_Human | 2.34872091 |
30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.31823185 |
31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.22058398 |
32 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.05713324 |
33 | MAF_26560356_Chip-Seq_TH2_Human | 2.05666101 |
34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01165073 |
35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00940162 |
36 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94815925 |
37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.86108192 |
38 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.80285210 |
39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.79246485 |
40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77929411 |
41 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76325682 |
42 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76232356 |
43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.69729512 |
44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67819172 |
45 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56421792 |
46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.53462627 |
47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.52403713 |
48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.51909776 |
49 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.50975204 |
50 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.50686581 |
51 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.49488556 |
52 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48573564 |
53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.48059022 |
54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47149292 |
55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.44078404 |
56 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41145627 |
57 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38263755 |
58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.36267724 |
59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.35076348 |
60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.34233747 |
61 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33986542 |
62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.33566318 |
63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31594273 |
64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.31578058 |
65 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29499739 |
66 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28294339 |
67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.27788828 |
68 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27559315 |
69 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24036140 |
70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.22772972 |
71 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22343822 |
72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22238344 |
73 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21653757 |
74 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20980477 |
75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20337647 |
76 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17990064 |
77 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14839342 |
78 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.14794825 |
79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12606415 |
80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12295368 |
81 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.11827784 |
82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09053608 |
83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06352499 |
84 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04495012 |
85 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04313608 |
86 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.04158253 |
87 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.02959715 |
88 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02421025 |
89 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01387964 |
90 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00736085 |
91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98360140 |
92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.96997951 |
93 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96871934 |
94 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95820633 |
95 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.93238274 |
96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92250848 |
97 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.89893894 |
98 | P300_27268052_Chip-Seq_Bcells_Human | 0.89458074 |
99 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88499356 |
100 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85689254 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 4.39690299 |
2 | MP0003436_decreased_susceptibility_to | 3.99061560 |
3 | MP0001835_abnormal_antigen_presentation | 3.96552924 |
4 | MP0005671_abnormal_response_to | 3.55120897 |
5 | MP0003763_abnormal_thymus_physiology | 3.25846054 |
6 | MP0005000_abnormal_immune_tolerance | 3.09157589 |
7 | MP0001800_abnormal_humoral_immune | 3.08278337 |
8 | MP0002419_abnormal_innate_immunity | 3.03417472 |
9 | MP0005025_abnormal_response_to | 3.00724801 |
10 | MP0003303_peritoneal_inflammation | 2.96607657 |
11 | MP0009785_altered_susceptibility_to | 2.91836763 |
12 | MP0000685_abnormal_immune_system | 2.87796007 |
13 | MP0002420_abnormal_adaptive_immunity | 2.77612759 |
14 | MP0002723_abnormal_immune_serum | 2.75474397 |
15 | MP0001819_abnormal_immune_cell | 2.73777021 |
16 | MP0001790_abnormal_immune_system | 2.67152112 |
17 | MP0005387_immune_system_phenotype | 2.67152112 |
18 | MP0002452_abnormal_antigen_presenting | 2.61431754 |
19 | MP0005464_abnormal_platelet_physiology | 2.47359723 |
20 | MP0002148_abnormal_hypersensitivity_rea | 2.32719465 |
21 | MP0002398_abnormal_bone_marrow | 2.31304743 |
22 | MP0009278_abnormal_bone_marrow | 2.22124406 |
23 | MP0002405_respiratory_system_inflammati | 2.18307460 |
24 | MP0000716_abnormal_immune_system | 2.17009812 |
25 | MP0002396_abnormal_hematopoietic_system | 2.04312673 |
26 | MP0006082_CNS_inflammation | 2.01380805 |
27 | MP0000465_gastrointestinal_hemorrhage | 1.98661624 |
28 | MP0001533_abnormal_skeleton_physiology | 1.96433417 |
29 | MP0002722_abnormal_immune_system | 1.90285313 |
30 | MP0003866_abnormal_defecation | 1.89921386 |
31 | MP0000689_abnormal_spleen_morphology | 1.88858292 |
32 | MP0009333_abnormal_splenocyte_physiolog | 1.88601747 |
33 | MP0002166_altered_tumor_susceptibility | 1.87611244 |
34 | MP0010155_abnormal_intestine_physiology | 1.84583156 |
35 | MP0000703_abnormal_thymus_morphology | 1.82831245 |
36 | MP0001845_abnormal_inflammatory_respons | 1.79257852 |
37 | MP0003172_abnormal_lysosome_physiology | 1.75522649 |
38 | MP0003191_abnormal_cellular_cholesterol | 1.75341444 |
39 | MP0002429_abnormal_blood_cell | 1.74999510 |
40 | MP0004947_skin_inflammation | 1.74786968 |
41 | MP0003300_gastrointestinal_ulcer | 1.71602664 |
42 | MP0005397_hematopoietic_system_phenotyp | 1.66631965 |
43 | MP0001545_abnormal_hematopoietic_system | 1.66631965 |
44 | MP0002132_abnormal_respiratory_system | 1.62913098 |
45 | MP0008260_abnormal_autophagy | 1.51650034 |
46 | MP0003828_pulmonary_edema | 1.44981569 |
47 | MP0005075_abnormal_melanosome_morpholog | 1.44701701 |
48 | MP0009764_decreased_sensitivity_to | 1.43768689 |
49 | MP0004381_abnormal_hair_follicle | 1.41878364 |
50 | MP0008469_abnormal_protein_level | 1.39274806 |
51 | MP0001851_eye_inflammation | 1.34123053 |
52 | MP0002009_preneoplasia | 1.31441925 |
53 | MP0002006_tumorigenesis | 1.26729295 |
54 | MP0000858_altered_metastatic_potential | 1.19323533 |
55 | MP0002933_joint_inflammation | 1.13983740 |
56 | MP0005310_abnormal_salivary_gland | 1.10722643 |
57 | MP0004808_abnormal_hematopoietic_stem | 1.10600679 |
58 | MP0003656_abnormal_erythrocyte_physiolo | 1.10565785 |
59 | MP0001873_stomach_inflammation | 1.10152005 |
60 | MP0002277_abnormal_respiratory_mucosa | 1.09151833 |
61 | MP0003183_abnormal_peptide_metabolism | 1.05424314 |
62 | MP0004883_abnormal_blood_vessel | 0.98278344 |
63 | MP0003075_altered_response_to | 0.96777204 |
64 | MP0002998_abnormal_bone_remodeling | 0.96660424 |
65 | MP0001853_heart_inflammation | 0.94901234 |
66 | MP0009763_increased_sensitivity_to | 0.92114622 |
67 | MP0001986_abnormal_taste_sensitivity | 0.88497199 |
68 | MP0005058_abnormal_lysosome_morphology | 0.88360625 |
69 | MP0008004_abnormal_stomach_pH | 0.85149072 |
70 | MP0002019_abnormal_tumor_incidence | 0.85133436 |
71 | MP0003045_fibrosis | 0.82379197 |
72 | MP0002138_abnormal_hepatobiliary_system | 0.81373724 |
73 | MP0005390_skeleton_phenotype | 0.80824335 |
74 | MP0003806_abnormal_nucleotide_metabolis | 0.80793967 |
75 | MP0000015_abnormal_ear_pigmentation | 0.79556310 |
76 | MP0001663_abnormal_digestive_system | 0.79178290 |
77 | MP0005166_decreased_susceptibility_to | 0.78821011 |
78 | MP0005164_abnormal_response_to | 0.77663875 |
79 | MP0003448_altered_tumor_morphology | 0.75959220 |
80 | MP0009765_abnormal_xenobiotic_induced | 0.74284417 |
81 | MP0000490_abnormal_crypts_of | 0.73429287 |
82 | MP0005451_abnormal_body_composition | 0.70986401 |
83 | MP0004130_abnormal_muscle_cell | 0.66766388 |
84 | MP0003795_abnormal_bone_structure | 0.62036955 |
85 | MP0008057_abnormal_DNA_replication | 0.60304642 |
86 | MP0003690_abnormal_glial_cell | 0.59088305 |
87 | MP0004510_myositis | 0.58075342 |
88 | MP0000249_abnormal_blood_vessel | 0.55367376 |
89 | MP0008874_decreased_physiological_sensi | 0.54056177 |
90 | MP0005174_abnormal_tail_pigmentation | 0.53063608 |
91 | MP0002693_abnormal_pancreas_physiology | 0.50135994 |
92 | MP0005376_homeostasis/metabolism_phenot | 0.48966592 |
93 | MP0008873_increased_physiological_sensi | 0.47130755 |
94 | MP0000604_amyloidosis | 0.46003314 |
95 | MP0000343_altered_response_to | 0.45053328 |
96 | MP0005535_abnormal_body_temperature | 0.44327384 |
97 | MP0000609_abnormal_liver_physiology | 0.43810109 |
98 | MP0005319_abnormal_enzyme/_coenzyme | 0.42675131 |
99 | MP0005083_abnormal_biliary_tract | 0.42520791 |
100 | MP0004185_abnormal_adipocyte_glucose | 0.41656963 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 6.11093058 |
2 | Recurrent abscess formation (HP:0002722) | 5.53658904 |
3 | Myositis (HP:0100614) | 5.38974774 |
4 | Stomatitis (HP:0010280) | 5.32908491 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.31298811 |
6 | Recurrent bacterial skin infections (HP:0005406) | 5.31270680 |
7 | Abnormality of macrophages (HP:0004311) | 4.78175534 |
8 | Orchitis (HP:0100796) | 4.71585762 |
9 | Optic neuritis (HP:0100653) | 4.56790423 |
10 | Retrobulbar optic neuritis (HP:0100654) | 4.56790423 |
11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.53713953 |
12 | Recurrent fungal infections (HP:0002841) | 4.49418382 |
13 | Meningitis (HP:0001287) | 4.20718672 |
14 | Obstructive lung disease (HP:0006536) | 4.07625378 |
15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.07625378 |
16 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.02045562 |
17 | Encephalitis (HP:0002383) | 3.99630390 |
18 | Gastrointestinal infarctions (HP:0005244) | 3.97134024 |
19 | Mediastinal lymphadenopathy (HP:0100721) | 3.94150115 |
20 | T lymphocytopenia (HP:0005403) | 3.93223229 |
21 | Panhypogammaglobulinemia (HP:0003139) | 3.84444346 |
22 | Recurrent skin infections (HP:0001581) | 3.77307690 |
23 | Prolonged bleeding time (HP:0003010) | 3.77085543 |
24 | Abnormality of T cell number (HP:0011839) | 3.77000933 |
25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.71353131 |
26 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.71353131 |
27 | Increased IgE level (HP:0003212) | 3.65818210 |
28 | Keratoconjunctivitis sicca (HP:0001097) | 3.63965996 |
29 | Abnormality of T cells (HP:0002843) | 3.48300175 |
30 | Hypochromic microcytic anemia (HP:0004840) | 3.45266146 |
31 | Vasculitis (HP:0002633) | 3.40488602 |
32 | Keratoconjunctivitis (HP:0001096) | 3.39628481 |
33 | Cellulitis (HP:0100658) | 3.34470522 |
34 | Granulocytopenia (HP:0001913) | 3.28889050 |
35 | Spontaneous hematomas (HP:0007420) | 3.28325554 |
36 | Recurrent viral infections (HP:0004429) | 3.27102186 |
37 | Chest pain (HP:0100749) | 3.25936315 |
38 | Leukocytosis (HP:0001974) | 3.25556180 |
39 | Agammaglobulinemia (HP:0004432) | 3.22842517 |
40 | Urticaria (HP:0001025) | 3.22224446 |
41 | Inflammation of the large intestine (HP:0002037) | 3.18698227 |
42 | Epistaxis (HP:0000421) | 3.16188723 |
43 | Autoimmune hemolytic anemia (HP:0001890) | 3.11620171 |
44 | Hypochromic anemia (HP:0001931) | 3.10200757 |
45 | Gastrointestinal inflammation (HP:0004386) | 3.09910345 |
46 | Pustule (HP:0200039) | 3.08507583 |
47 | Episodic fever (HP:0001954) | 3.06158358 |
48 | Gingival bleeding (HP:0000225) | 3.03281429 |
49 | Severe combined immunodeficiency (HP:0004430) | 2.99777829 |
50 | Gingivitis (HP:0000230) | 2.98564612 |
51 | Increased IgM level (HP:0003496) | 2.94448140 |
52 | Pulmonary infiltrates (HP:0002113) | 2.90607551 |
53 | Abnormality of T cell physiology (HP:0011840) | 2.89421584 |
54 | Petechiae (HP:0000967) | 2.85247867 |
55 | Hemoptysis (HP:0002105) | 2.77720162 |
56 | Eosinophilia (HP:0001880) | 2.76341424 |
57 | Arterial thrombosis (HP:0004420) | 2.74758913 |
58 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.70663006 |
59 | Anorexia (HP:0002039) | 2.70081606 |
60 | Abnormality of eosinophils (HP:0001879) | 2.65722293 |
61 | Colitis (HP:0002583) | 2.65513048 |
62 | Lymphopenia (HP:0001888) | 2.65393790 |
63 | Autoimmune thrombocytopenia (HP:0001973) | 2.57696505 |
64 | Hypergammaglobulinemia (HP:0010702) | 2.51709706 |
65 | Pulmonary embolism (HP:0002204) | 2.51085584 |
66 | Microcytic anemia (HP:0001935) | 2.50258636 |
67 | IgM deficiency (HP:0002850) | 2.49696499 |
68 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48423530 |
69 | Sepsis (HP:0100806) | 2.47074672 |
70 | Osteomyelitis (HP:0002754) | 2.44343505 |
71 | Abnormality of the prostate (HP:0008775) | 2.40308298 |
72 | Abnormality of the pleura (HP:0002103) | 2.37700244 |
73 | IgG deficiency (HP:0004315) | 2.34254371 |
74 | Combined immunodeficiency (HP:0005387) | 2.30655900 |
75 | Abnormality of B cell number (HP:0010975) | 2.29674628 |
76 | Gangrene (HP:0100758) | 2.24464695 |
77 | Hepatosplenomegaly (HP:0001433) | 2.16386885 |
78 | Chronic otitis media (HP:0000389) | 2.14125256 |
79 | Papilloma (HP:0012740) | 2.13419796 |
80 | Verrucae (HP:0200043) | 2.13419796 |
81 | Abnormality of iron homeostasis (HP:0011031) | 2.13188531 |
82 | Joint swelling (HP:0001386) | 2.11604883 |
83 | Recurrent bronchitis (HP:0002837) | 2.11595185 |
84 | Stomach cancer (HP:0012126) | 2.11287150 |
85 | Peritonitis (HP:0002586) | 2.09931699 |
86 | Purpura (HP:0000979) | 2.09134302 |
87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.08995048 |
88 | Increased serum ferritin (HP:0003281) | 2.08298859 |
89 | Skin rash (HP:0000988) | 2.06632048 |
90 | Skin ulcer (HP:0200042) | 2.04104086 |
91 | Increased cerebral lipofuscin (HP:0011813) | 2.00837743 |
92 | Acute hepatic failure (HP:0006554) | 2.00563218 |
93 | Slow saccadic eye movements (HP:0000514) | 2.00238085 |
94 | Chronic diarrhea (HP:0002028) | 1.99807707 |
95 | Vertigo (HP:0002321) | 1.98887447 |
96 | B lymphocytopenia (HP:0010976) | 1.97271375 |
97 | Glomerulopathy (HP:0100820) | 1.96787295 |
98 | Viral hepatitis (HP:0006562) | 1.96396191 |
99 | Prostate neoplasm (HP:0100787) | 1.95330189 |
100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93564077 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.42936584 |
2 | RIPK4 | 3.94666913 |
3 | FES | 2.97850847 |
4 | GRK6 | 2.81177881 |
5 | TXK | 2.78210585 |
6 | MAP2K3 | 2.70980441 |
7 | IRAK4 | 2.59607555 |
8 | TAOK3 | 2.57979435 |
9 | ZAP70 | 2.49672177 |
10 | TESK2 | 2.44025463 |
11 | TYK2 | 2.43527249 |
12 | BLK | 2.39745912 |
13 | BTK | 2.36997387 |
14 | TNK2 | 2.27286844 |
15 | CSK | 2.15572111 |
16 | SYK | 2.15568976 |
17 | MAP3K11 | 2.02147445 |
18 | IKBKE | 1.98051048 |
19 | ERN1 | 1.95604931 |
20 | MAP3K14 | 1.90480901 |
21 | KIT | 1.85381795 |
22 | HCK | 1.84096418 |
23 | PRPF4B | 1.83280506 |
24 | ITK | 1.79475727 |
25 | TEC | 1.78959716 |
26 | KDR | 1.78758036 |
27 | JAK3 | 1.78041808 |
28 | CSF1R | 1.60956131 |
29 | TBK1 | 1.54053244 |
30 | LYN | 1.50395441 |
31 | LCK | 1.48065051 |
32 | EPHB1 | 1.38101810 |
33 | JAK1 | 1.37880709 |
34 | TAOK1 | 1.29183900 |
35 | FGR | 1.25205155 |
36 | IKBKB | 1.16301345 |
37 | JAK2 | 1.15563032 |
38 | MAP3K3 | 1.11798263 |
39 | MARK3 | 1.11072957 |
40 | MAP3K13 | 1.04664619 |
41 | IRAK1 | 0.99822698 |
42 | PIK3CG | 0.96846650 |
43 | MAP3K1 | 0.90348611 |
44 | PRKCQ | 0.87545848 |
45 | MAP3K6 | 0.87527057 |
46 | TAOK2 | 0.87459899 |
47 | SIK3 | 0.85204538 |
48 | BMPR2 | 0.83264143 |
49 | MATK | 0.81328326 |
50 | PDK1 | 0.73795937 |
51 | BCKDK | 0.73228344 |
52 | MAP3K5 | 0.72603152 |
53 | PIM1 | 0.71687334 |
54 | SIK2 | 0.70072061 |
55 | CDK19 | 0.68018959 |
56 | MARK2 | 0.67702319 |
57 | MAP3K7 | 0.62971449 |
58 | MAP2K6 | 0.62384605 |
59 | FYN | 0.62357839 |
60 | STK10 | 0.62251486 |
61 | PRKD2 | 0.61339425 |
62 | SCYL2 | 0.59762832 |
63 | HIPK2 | 0.56031268 |
64 | IRAK2 | 0.56025770 |
65 | MAPK12 | 0.53174050 |
66 | EPHA3 | 0.52249743 |
67 | LRRK2 | 0.50816045 |
68 | MAP2K2 | 0.49338368 |
69 | NLK | 0.48277167 |
70 | YES1 | 0.46256151 |
71 | PTK6 | 0.45740202 |
72 | RET | 0.44492029 |
73 | MAPKAPK2 | 0.44171981 |
74 | PDPK1 | 0.43541344 |
75 | CAMKK1 | 0.43156989 |
76 | MAPK7 | 0.43122233 |
77 | RPS6KL1 | 0.43016137 |
78 | RPS6KC1 | 0.43016137 |
79 | MAPK11 | 0.42512092 |
80 | SMG1 | 0.40820665 |
81 | DAPK2 | 0.40604256 |
82 | PTK2B | 0.40581865 |
83 | CAMKK2 | 0.39431451 |
84 | FGFR3 | 0.39110607 |
85 | RPS6KA6 | 0.38925461 |
86 | DYRK1B | 0.38916403 |
87 | TRIB3 | 0.38301187 |
88 | CDK12 | 0.36607898 |
89 | CDK4 | 0.35655361 |
90 | MAP2K4 | 0.33094940 |
91 | KSR2 | 0.32569528 |
92 | FGFR4 | 0.31420865 |
93 | STK11 | 0.31329149 |
94 | ABL1 | 0.29230937 |
95 | MAPK3 | 0.28646612 |
96 | CLK1 | 0.26610967 |
97 | RAF1 | 0.25339711 |
98 | BMX | 0.25283861 |
99 | GRK7 | 0.25213151 |
100 | CDK6 | 0.24900203 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.70578337 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.95830541 |
3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.75681997 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.69716896 |
5 | Allograft rejection_Homo sapiens_hsa05330 | 2.63218970 |
6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.53393610 |
7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.52807412 |
8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.49389237 |
9 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.33169060 |
10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.27300268 |
11 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.18970302 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.06557661 |
13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.03233560 |
14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.03197549 |
15 | Measles_Homo sapiens_hsa05162 | 1.99514914 |
16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98035262 |
17 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.97287593 |
18 | Malaria_Homo sapiens_hsa05144 | 1.95166723 |
19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94259385 |
20 | Tuberculosis_Homo sapiens_hsa05152 | 1.88052717 |
21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83919334 |
22 | Asthma_Homo sapiens_hsa05310 | 1.75150702 |
23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.71864458 |
24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69761492 |
25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.68882946 |
26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.62743707 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.60338949 |
28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.53079500 |
29 | Legionellosis_Homo sapiens_hsa05134 | 1.45380778 |
30 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44952539 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.44266315 |
32 | Influenza A_Homo sapiens_hsa05164 | 1.43858714 |
33 | Platelet activation_Homo sapiens_hsa04611 | 1.42927872 |
34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41255587 |
35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.39778754 |
36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27790102 |
37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21784785 |
38 | Shigellosis_Homo sapiens_hsa05131 | 1.20939681 |
39 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.20701967 |
40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.18475282 |
41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13611865 |
42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.12733565 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.09916811 |
44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08623301 |
45 | Hepatitis B_Homo sapiens_hsa05161 | 1.08492601 |
46 | Pertussis_Homo sapiens_hsa05133 | 1.01714755 |
47 | Phagosome_Homo sapiens_hsa04145 | 0.99356354 |
48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99291710 |
49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.92510436 |
50 | Apoptosis_Homo sapiens_hsa04210 | 0.88811298 |
51 | Hepatitis C_Homo sapiens_hsa05160 | 0.88101842 |
52 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87251457 |
53 | Salmonella infection_Homo sapiens_hsa05132 | 0.86864627 |
54 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86518650 |
55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82338668 |
56 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78976554 |
57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77078415 |
58 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76519601 |
59 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71389320 |
60 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70595070 |
61 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69686111 |
62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.69401231 |
63 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68523707 |
64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64351633 |
65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62352988 |
66 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60887853 |
67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.60257160 |
68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59993913 |
69 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.59805018 |
70 | Endocytosis_Homo sapiens_hsa04144 | 0.59669382 |
71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58822967 |
72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55856705 |
73 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55723525 |
74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55306351 |
75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53724096 |
76 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51364668 |
77 | Lysosome_Homo sapiens_hsa04142 | 0.50928298 |
78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49897442 |
79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44997147 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.44323764 |
81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43479771 |
82 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.41600842 |
83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41307331 |
84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41094332 |
85 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40858817 |
86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39203519 |
87 | Amoebiasis_Homo sapiens_hsa05146 | 0.36469699 |
88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32636653 |
89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.30838843 |
90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27911571 |
91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26997700 |
92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.26882716 |
93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.26856818 |
94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.26153206 |
95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25652609 |
96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25294388 |
97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.24870996 |
98 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24788127 |
99 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24616501 |
100 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.23789836 |